Celvive is to refine a technology for the isolation and use of autologous stem cells for regenerative medicine applications with an initial focus on neural regeneration in patients with spinal cord injury (SCI).

Celvive, Inc.
Management
Technology
Deals/Partnering
Research Pipeline
Funding
BioStartup's Score
0 / 50
KEY DETAILS
Websitehttp://www.celvive.com
Founded2011
Disease Focus
Development Stage
STOCK CODENon Listed
Address120 Albany Street,Tower II, Suite 850, NJ 08901New BrunswickUnited States
120 Albany Street,Tower II, Suite 850, NJ 08901
New Brunswick
United States
Contact Number+1 908 731-6610
+1 908 731-6610
[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/celvive-inc.” connections=”true” suffix=””]
Celvive has generated a closed system (The StemCell bag_) that consists of sterile, single-use disposable sets of bags and attachments connected to a microprocessor-controlled instrument to enable the isolation of matrix stem cells in a functionally closed system. These autologous stem cells are separated in the StemCellë bag can be injected back into the patient via intrathecal injections.